The Role of School-Based Health Centres in Advancing Health Equity

By Melike Belenli Gümüş

October 3, 2024

Introduction

School-based health centres (SBHCs) are crucial in providing healthcare services to underserved youth in the United States. These centres provide essential healthcare services directly within schools, ensuring that students have easy access to medical care. Located in elementary, middle, and high schools, SBHCs primarily serve low-income communities, offering primary care, reproductive health, mental health, dental, vision, and nutrition services. These centres are staffed by a multidisciplinary team, including physicians, nurse practitioners, mental health providers. SBHCs improve both health and educational outcomes by increasing access to care and partnering with schools and paediatric healthcare providers. They play an important role in both advancing health equity and enhancing educational outcomes.

Background and Current State

The origins of SBHCs date back to the 1960s and 1970s. These early centres aimed to enhance care for underserved students and improve prenatal care for teen mothers. As of the 2016-2017 Census by the School-Based Health Alliance (SBHA), there are 2,584 SBHCs across 48 states, Puerto Rico, and the District of Columbia. These centres serve over 6 million students in various communities. Most SBHCs are located on school campuses, while others are mobile or telehealth-exclusive. Federally qualified health centres sponsor 51% of SBHCs, and all provide primary care services.

SBHCs and Access to Care

SBHCs are instrumental in bridging gaps in care for underserved youth, particularly those who are uninsured or underinsured. These centres offer comprehensive medical services, including preventive care, management of chronic conditions, and reproductive health services. By providing care on-site, SBHCs reduce the need for travel and ensure that students miss less school. Confidentiality is maintained, allowing adolescents to seek care without parental involvement.

Management of Chronic Health Conditions

SBHCs play a crucial role in managing chronic health conditions like asthma and obesity. Asthma is the most common chronic illness in children. SBHCs can initiate treatment, provide urgent care, and promote medication adherence. Studies have shown that SBHCs reduce asthma-related hospitalisations and improve school attendance.

Childhood obesity is another significant concern, particularly those from low-income households. SBHCs screen for obesity and related conditions and offer educational interventions. A study in New Mexico found that a SBHC weight management program led to improvements in body mass index (BMI) and waist circumference.

The Role of SBHCs in Advancing Health Equity

A Community Guide systematic review in 2016 highlighted the effectiveness of SBHCs in improving educational and health-related outcomes. According to this review, SBHCs were associated with higher grade point average (GPA), grade promotion, and reduced school suspensions. Health outcomes improved as well, with increased immunisation rates, reduced asthma-related hospitalisations, and better reproductive health indicators.

Educational Outcomes

SBHCs positively impact educational outcomes by reducing absenteeism and improving academic performance. Studies have shown that SBHC users have higher GPAs and are more likely to be promoted to the next grade. One study found that SBHC use was associated with a 33% reduction in school dropout rates, particularly among high-risk students. SBHCs also support pregnant adolescents, helping them stay in school and achieve better educational outcomes.

Cost Effectiveness of SBHCs

SBHCs are not only beneficial for students but also cost-effective, reducing healthcare and societal costs. They decrease emergency department visits, hospitalisations, and missed time from work and school, providing a high return on investment. Wade and Guo demonstrated that SBHCs reduce Medicaid costs by improving students’ health-related quality of life (HRQoL). Moreover, a systematic review found that the societal benefit of SBHCs ranged from $15,028 to $912,878 annually. Another study in Ohio reported a net social benefit of $1.35 million over three years of SBHC operation.

Conclusion

SBHCs are important healthcare facilities that promote health equity among youth and improve their educational outcomes. They reduce health disparities, offer cost-effective care, and support the academic success of students. However, there are several challenges that SBHCs face. Many SBHCs rely on grants and external funding, which can be unpredictable. Moreover, there is a need for better integration with primary care providers to ensure continuity of care. Future efforts should focus on securing stable funding sources and enhancing collaboration between SBHCs and other healthcare providers.

Reference url

Recent Posts

DTC telehealth partnerships
           

DTC Telehealth Partnerships: Navigating Risks in Pharma’s Digital Expansion

🚀 Are pharmaceutical companies’ DTC telehealth partnerships reshaping healthcare for better or worse?

Recent findings from the “DTC Investigation 2025” report reveal key insights into the high prescription rates and potential risks of these digital platforms operated by giants like Pfizer and Eli Lilly. Alarmingly, inadequate clinical safeguards raise questions about patient safety, prescribing practices, and cost implications.

Dive into this critical discussion about the intersection of digital health and pharmaceutical practices, and explore what it means for the future of patient care.

#SyenzaNews #DigitalHealth #HealthEconomics #HealthcarePolicy

MAF Test breast cancer
       

MAF Test Breast Cancer: Revolutionizing Personalized Treatment in Spanish Oncology

🌟 How can personalized medicine transform breast cancer treatment in Spain?

The recent rollout of the MAF Test breast cancer in leading Spanish hospitals is set to revolutionize patient care by enabling targeted treatment strategies. This innovative molecular assay not only identifies patients who will benefit from bisphosphonates but also spares those for whom the treatment may be harmful, ultimately improving outcomes for thousands.

Dive into the article to discover how this approach aligns with global trends in oncology and enhances healthcare resource allocation.

#SyenzaNews #precisionmedicine #HealthEconomics #innovation

ribociclib breast cancer guidance
           

NICE’s Ribociclib Breast Cancer Guidance: A New Era for High-Risk Patients in the NHS

🌟 Are we on the brink of transforming breast cancer treatment?

NICE’s latest guidance endorsing ribociclib in combination with an aromatase inhibitor marks a significant advancement for adults facing high-risk early breast cancer. This decision not only promises enhanced survival outcomes but also expands treatment options for patients historically limited to conventional therapies.

Dive into the details of this important development and learn how it may revolutionize patient care in the oncology landscape.

#SyenzaNews #oncology #costeffectiveness #MarketAccess

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

JOIN NEWSLETTER

© 2025 Syenza™. All rights reserved.